| 20th May 2025 1:25 pm |
RNS |
Holding(s) in Company |
| 12th May 2025 7:00 am |
RNS |
Inaphaea Deal Extension With Dominion |
| 30th Apr 2025 7:00 am |
RNS |
Commercial Update |
| 3rd Apr 2025 7:00 am |
RNS |
Termination of Letter of Intent with TheoremRx |
| 27th Mar 2025 7:00 am |
RNS |
Directorate Changes and new Advisory Board |
| 21st Mar 2025 11:07 am |
RNS |
Director Disclosure Update |
| 24th Feb 2025 7:00 am |
RNS |
Conclusion of Evaluation Project |
| 3rd Feb 2025 7:00 am |
RNS |
Inaphaea Evaluation and Commercial Use Agreement |
| 30th Jan 2025 7:00 am |
RNS |
Extension of Evaluation Agreement |
| 29th Jan 2025 7:00 am |
RNS |
New Evaluation and Option Agreement |
| 15th Jan 2025 12:47 pm |
RNS |
Holding(s) in Company |
| 15th Jan 2025 11:29 am |
RNS |
Holding(s) in Company |
| 14th Jan 2025 7:00 am |
RNS |
Holding(s) in Company |
| 9th Jan 2025 11:37 am |
RNS |
Holding(s) in Company |
| 9th Jan 2025 11:14 am |
RNS |
Holding(s) in Company |
| 8th Jan 2025 7:00 am |
RNS |
Holding(s) in Company |
| 2nd Jan 2025 11:45 am |
RNS |
Holding(s) in Company |
| 31st Dec 2024 1:06 pm |
RNS |
Holding(s) in Company |
| 31st Dec 2024 8:39 am |
RNS |
Update on proposed sub-license of VAL201 |
| 30th Dec 2024 1:30 pm |
RNS |
Result of GM, Issue of Equity, Warrants and TVR |
| 20th Dec 2024 7:00 am |
RNS-R |
ValiRx launches new interactive investor website |
| 10th Dec 2024 4:45 pm |
RNS |
Broker Offer Results & Director/PDMR Subscription |
| 10th Dec 2024 3:03 pm |
RNS |
Posting of Circular and Notice of General Meeting |
| 9th Dec 2024 7:00 am |
RNS |
Conditional Fundraising & Launch of Broker Offer |
| 22nd Nov 2024 7:00 am |
RNS |
Inaphaea award of HEIF Funding and PhD sponsorship |
| 20th Nov 2024 7:00 am |
RNS |
Update on proposed sub-license of VAL401 |
| 19th Nov 2024 7:00 am |
RNS |
Contract Award |
| 18th Nov 2024 7:00 am |
RNS |
First Sale of New Product Line |
| 30th Oct 2024 7:00 am |
RNS |
Update on proposed sub-license of VAL201 |
| 18th Oct 2024 7:00 am |
RNS |
Directorate Change |
| 14th Oct 2024 7:00 am |
RNS |
Investor Webinar |
| 7th Oct 2024 7:00 am |
RNS |
Inaphaea Co-Marketing Agreement |
| 27th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 26th Sep 2024 7:00 am |
RNS |
Conclusion of Evaluation Project |
| 24th Sep 2024 7:00 am |
RNS |
Inaphaea Co-Marketing Agreement |
| 18th Sep 2024 7:00 am |
RNS |
Inaphaea Evaluation and Commercial Use Agreement |
| 16th Sep 2024 7:00 am |
RNS |
Inaphaea Co-Marketing Agreement |
| 9th Sep 2024 7:00 am |
RNS |
Inaphaea Evaluation and Commercial Use Agreement |
| 9th Sep 2024 7:00 am |
RNS |
Investor Evening |
| 27th Aug 2024 7:00 am |
RNS |
Inaphaea Evaluation and Commercial Use Agreement |
